Thus, our findings support simultaneously targeting of COX2/PGE2 and PD-1 signaling as an efficacious treatment for cancer where CTLs exhaustion in human tumor microenvironment (TME) is known to occur. This evidence concerns the gene PDCD1 and cancer.